Detalles de la búsqueda
1.
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.
N Engl J Med
; 386(7): 629-639, 2022 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34904798
2.
Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors.
Haematologica
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38721749
3.
Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee.
Cytotherapy
; 2024 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38483362
4.
COVID-19 outcomes in haemopoietic stem cell transplant recipients in Western Australia: the value of vaccination and antiviral therapy.
Intern Med J
; 54(4): 664-670, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38572768
5.
Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering.
Cytotherapy
; 25(5): 463-471, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36710227
6.
Engineering the best transplant outcome for high-risk acute myeloid leukemia: the donor, the graft and beyond.
Cytotherapy
; 2023 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38054912
7.
International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant.
Cytotherapy
; 25(6): 578-589, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36941149
8.
Letermovir for pre-emptive cytomegalovirus therapy after allogeneic hematopoietic cell transplantation.
Transpl Infect Dis
; 25 Suppl 1: e14147, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676725
9.
Allogeneic haemopoietic cell transplant services in Australia and New Zealand in the first year of the COVID-19 pandemic: a report from Australia and New Zealand transplant and cellular therapies.
Intern Med J
; 53(3): 323-329, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35833788
10.
ANZTCT consensus position statement on ruxolitinib in steroid-refractory acute and chronic graft-versus-host disease.
Intern Med J
; 53(12): 2319-2329, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38014511
11.
Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell.
Intern Med J
; 53(1): 119-125, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36371767
12.
Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation.
Cytotherapy
; 24(3): 249-261, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34879990
13.
An ISCT Stem Cell Engineering Committee Position Statement on Immune Reconstitution: the importance of predictable and modifiable milestones of immune reconstitution to transplant outcomes.
Cytotherapy
; 24(4): 385-392, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35331394
14.
Viral infection in hematopoietic stem cell transplantation: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review on the role of cellular therapy in prevention and treatment.
Cytotherapy
; 24(9): 884-891, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35705447
15.
QuantiFERON-cytomegalovirus to predict clinically significant cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
Transpl Infect Dis
; 24(2): e13786, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34994053
16.
Effect of donor age on adult unrelated donor haemopoietic cell transplant outcome: the Australian experience.
Intern Med J
; 52(1): 57-62, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33131163
17.
Diagnosis, management and follow up of peripheral T-cell lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance.
Intern Med J
; 52(10): 1806-1817, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34668281
18.
High dose valaciclovir to prevent cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients.
Transpl Infect Dis
; 23(4): e13633, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33978289
19.
Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statement.
Intern Med J
; 51(8): 1321-1323, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34423546
20.
Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
Biol Blood Marrow Transplant
; 26(9): 1711-1718, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32194285